Expression of pro-angiogenic factors in malignant melanoma and their regulation by low-dose interferon-α

被引：0
|
作者：
M. Go
J. Biber
G. B. Lesinski
W. E. Carson
机构：
[1] Surgery,
[2] The Ohio State University,undefined
来源：
Annals of Surgical Oncology | 2004年 / 11卷
关键词：
Melanoma; Vascular Endothelial Growth Factor; Sentinel Node Biopsy; Vascular Endothelial Growth Factor Level; Human Melanoma Cell Line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：S122 / S122
相关论文
共 50 条
  • [31] A phase II trial of bevacizumab with or without low-dose interferon-alpha in patients with metastatic malignant melanoma
    Varker, KA
    Kefauver, C
    Olencki, T
    Kendra, K
    Walker, MJ
    Carson, WE
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 18 - 18
  • [32] Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells
    Eisenreichi, Andreas
    Zakrzewicz, Andreas
    Huber, Kilian
    Thierbach, Hannes
    Pepke, Wojciech
    Goldin-Lang, Petra
    Schultheiss, Heinz-Peter
    Pries, Axel
    Rauch, Ursula
    ONCOLOGY REPORTS, 2013, 30 (01) : 462 - 470
  • [33] Low-dose leukocyte interferon-α therapy in dialysed patients with chronic Hepatitis C
    Benci, A
    Caremani, M
    Menchetti, D
    Sasdelli, M
    Giusti, PB
    CURRENT MEDICAL RESEARCH AND OPINION, 1998, 14 (03) : 141 - 144
  • [34] Low-dose natural human interferon-α lozenges in the treatment of Behcet's syndrome
    Kilic, Hasan
    Zeytin, Hasan E.
    Korkmaz, Cengiz
    Mat, Cem
    Gul, Ahmet
    Cosan, Fulya
    Dinc, Ayhan
    Simsek, Ismail
    Sut, Necdet
    Yazici, Hasan
    RHEUMATOLOGY, 2009, 48 (11) : 1388 - 1391
  • [35] BLCA1 expression is associated with angiogenesis of bladder cancer and is correlated with common pro-angiogenic factors
    Feng, Chenchen
    Wang, Lujia
    Ding, Guanxiong
    Jiang, Haowen
    Ding, Qiang
    Wu, Zhong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 16259 - 16265
  • [36] Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer
    Lutz Trojan
    Daniel Thomas
    Thomas Knoll
    Rainer Grobholz
    Peter Alken
    Maurice Stephan Michel
    Urological Research, 2004, 32 : 97 - 103
  • [37] Health Related Quality of Life (HRQOL) and Side-Effects in the Course of Low-Dose Interferon-Alpha Therapy in Malignant Melanoma-in Comparison to a Control Group Without Interferon- Alpha
    Albrecht, Karoline
    Meiss, Frank
    Nashan, Dorothee
    Reuter, Katrin
    PSYCHO-ONCOLOGY, 2013, 22 : 199 - 200
  • [38] FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression
    Yiming Su
    Yu Zhang
    Jing Zhao
    Wenhao Zhou
    Wenhao Wang
    Bangmin Han
    Xiaohai Wang
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3225 - 3243
  • [39] Depressive Mood Changes and Psychiatric Symptoms During 12-month Low-dose Interferon-α Treatment in Patients With Malignant Melanoma Results From the Multicenter DeCOG Trial
    Heinze, Sarah
    Egberts, Friederike
    Roetzer, Susanne
    Volkenandt, Matthias
    Tilgen, Wolfgang
    Linse, Ruthild
    Boettjer, Joerg
    Vogt, Thomas
    Spieth, Konstanze
    Eigentler, Thomas
    Brockmeyer, Norbert H.
    Hinzpeter, Axel
    Hauschild, Axel
    Schaefer, Martin
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (01) : 106 - 114
  • [40] FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression
    Su, Yiming
    Zhang, Yu
    Zhao, Jing
    Zhou, Wenhao
    Wang, Wenhao
    Han, Bangmin
    Wang, Xiaohai
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (11) : 3225 - 3243
12345